Key result
Global ALPK3 loss causes dilated cardiomyopathy and ~75% 1-month mortality in preclinical models.
Why the study?
The specific stages at which ALPK3 is essential for cardiac function and its regulatory mechanisms required further exploration.
Answers are grounded in this paper and cite their sources.
ALPK3 is essential for maintaining both neonatal and adult cardiac function, functioning as a scaffold protein to regulate thick filament protein turnover; its loss leads to dilated cardiomyopathy and subsequent hypertrophy, mirroring clinical manifestations of biallelic ALPK3 mutations.
BACKGROUND: ALPK3 (α protein kinase 3) is an atypical kinase highly expressed in human and murine hearts. Biallelic loss-of-function mutations in ALPK3 lead to pediatric cardiomyopathy. The specific stages at which ALPK3 is essential for cardiac function and the mechanisms by which it regulates cardiac function require further exploration. METHODS AND RESULTS: -3xFLAG-HA knock-in mouse model to determine endogenous ALPK3 localization. To investigate mechanisms of ALPK3 regulation, we performed biochemical assays and RNA sequencing experiments in global knockout mice. ALPK3 is critical for both neonatal and adult cardiac function. Loss of ALPK3 at germline and adult stages leads to dilated cardiomyopathy. Approximately 75% of germline ALPK3 mice die within 1 month, while surviving mutant mice develop dilated cardiomyopathy that transitions to left ventricular hypertrophy, mirroring clinical manifestations in human patients with biallelic ALPK3 mutations. We found that ALPK3 localizes to the M-band in both neonatal and adult cardiomyocytes and interacts with muscle RING-finger proteins, which may regulate thick filament protein turnover. CONCLUSIONS: Our study highlights the necessity of ALPK3 in neonatal and adult cardiac function. Our data support a model in which ALPK3 serves as a scaffold protein to recruit machineries essential for regulating thick filament protein turnover.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2025) studied Pediatric cardiomyopathy, Dilated cardiomyopathy. ALPK3 gene knockout vs. Wild-type littermate controls was evaluated on Mortality within 1 month (germline ALPK3 knockout). Global loss of ALPK3 in mice led to dilated cardiomyopathy and approximately 75% mortality within 1 month, mirroring the clinical manifestations of pediatric cardiomyopathy in humans with ALPK3 mutations.
Synapse has enriched 10 related papers. Consider them for comparative context: